Chandra S Chirumamilla
Overview
Explore the profile of Chandra S Chirumamilla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Logie E, Chirumamilla C, Perez-Novo C, Shaw P, Declerck K, Palagani A, et al.
Cancers (Basel)
. 2021 Apr;
13(7).
PMID: 33807411
Multiple myeloma (MM) is a hematological malignancy characterized by plasma cells' uncontrolled growth. The major barrier in treating MM is the occurrence of primary and acquired therapy resistance to anticancer...
2.
Milenkovic D, Vanden Berghe W, Morand C, Claude S, van de Sandt A, Gorressen S, et al.
Sci Rep
. 2018 Oct;
8(1):15487.
PMID: 30341379
Although vasculo-protective effects of flavan-3-ols are widely accepted today, their impact on endothelial cell functions and molecular mechanisms of action involved is not completely understood. The aim of this study...
3.
Chirumamilla C, Palagani A, Kamaraj B, Declerck K, Verbeek M, Oksana R, et al.
Front Immunol
. 2017 Nov;
8:1324.
PMID: 29163463
Synthetic glucocorticoids (GC) are the mainstay therapy for treatment of acute and chronic inflammatory disorders. Due to the high adverse effects associated with long-term use, GC pharmacology has focused since...